Long-Term Outcomes of the Maze Procedure Combined With Mitral Valve Repair: Risk of Thromboembolism Without Anticoagulation Therapy.

CONCLUSIONS: Adopting appropriate selection criteria for discontinuing anticoagulation therapy, the majority of patients receiving concomitant mitral repair and the Maze procedure can discontinue warfarin with excellent long-term safety profiles. PMID: 26116476 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26116476?dopt=Abstract

Source: The Annals of Thoracic Surgery - June 23, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Hwang SK, Yoo JS, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW Tags: Ann Thorac Surg Source Type: research